Remedy Robotics, a San Francisco-based medical robotics company, has raised $62 million in Series B funding to advance its AI-enabled N1 System for cardiovascular and neurovascular procedures. The funding will support clinical trials, regulatory approval efforts and further development of the robotic platform, which is designed to enable endovascular procedures through on-site, remote and potentially Read More
Newsletter
Get the Physical AI brief
The day’s most important robotics and embodied-AI stories, in your inbox.